Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.
Try us for 14 days
Try a trial subscription for access to our quality journalism
Oncology Venture has USD 8.7 million deficit after nine months
Biotech company Oncology Venture has significantly increased its deficit in the third quarter, and for the first three quarters as a whole, but the company's finances are comfortable going into 2020, says the new finance director.
